1. Circulating CD4+PD-1+ and CD8+PD-1+ T cells are profoundly decreased at the onset of fulminant type 1 diabetes and are restored by treatment, contrasting with CD4+CD25+FoxP3+ regulatory T cells. (November 2017) Authors: Iijima, Toshie; Kato, Kanako; Jojima, Teruo; Tomotsune, Takanori; Fukushima, Maiko; Suzuki, Kunihiro; Aso, Yoshimasa Journal: Diabetes research and clinical practice Issue: Volume 133(2017) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sitagliptin, a DPP-4 inhibitor, alters the subsets of circulating CD4+ T cells in patients with type 2 diabetes. Issue 3 (December 2015) Authors: Aso, Yoshimasa; Fukushima, Maiko; Sagara, Masaaki; Jojima, Teruo; Iijima, Toshie; Suzuki, Kunihiro; Momobayashi, Atsushi; Kasai, Kikuo; Inukai, Toshihiko Journal: Diabetes research and clinical practice Issue: Volume 110:Issue 3(2015) Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗